A rise in diabetes and obesity will drive the increase in the wound care market over the next four years, a research group asserts.
Chronic wounds can be stymied in healing when a patient has type 2 diabetes and obesity, both conditions that are on the rise. Other immunological or dermatological diseases can cause additional problems for wound care patients.
The $2,500 report, from ReportsnReports.com, examines the wound care market size up to 2018. “Global Advanced Wound Care Market 2014-2018” lists 3M, Coloplast, ConvaTec Inc., Kinetic Concepts Inc., Sweden’s Mölnlycke Health Care and Smith & Nephew as major players.
Other prominent vendors listed include C.R. Bard, Derma Sciences, Ethicon (a subsidiary of Johnson & Johnson), Hartmann USA and Systagenix Wound Management (Kinetic Concepts). Covidien, which was bought this year by Medtronic, also is listed.
The report notes that a challenge for vendors is a lack of clinical evidence, a point routinely hammered by academics looking at wounds in long-term care. A market trend will be increased demand for combination dressings over the next four years, the report asserts.